Delayed administration of pituitary adenylate cyclase-activating polypeptide 38 ameliorates renal ischemia/reperfusion injury in mice by modulating Toll-like receptors

Peptides

Volumn 38, Issue 2, 2012, Pages 395-403

  Khan, Altaf M ^a   Li, Min ^a   Abdulnour Nakhoul, Solange ^a   Maderdrut, Jerome L ^a   Simon, Eric E ^a,b   Batuman, Vecihi ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Apoptosis; Cytokines; Gene arrays; Innate immunity; Ischemia reperfusion; Peptides; Toll like receptors

Indexed keywords

CREATININE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; KIDNEY INJURY MOLECULE 1; NETRIN 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN CONJUGATING ENZYME E2;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; INNATE IMMUNITY; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THERAPY DELAY; UPREGULATION;

ANIMALS; APOPTOSIS; CREATININE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

MUS;

EID: 84868693824     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.09.023     Document Type: Article

References (55)

1. H.J. Anders, and D. Schlondorff Toll-like receptors: emerging concepts in kidney disease Curr Opin Nephrol Hypertens 16 2007 177 183
2. A. Arimura Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems Jpn J Physiol 48 1998 301 331
3. A. Arimura, M. Li, and V. Batuman Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury Blood 107 2006 661 668
4. A. Arimura, M. Li, and V. Batuman Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38 Ann NY Acad Sci 1070 2006 1 4
5. F. Arslan, B. Keogh, P. McGuirk, and A.E. Parker TLR2 and TLR4 in ischemia reperfusion injury Mediators Inflamm 2010 2011 704202
6. T.V. Arumugam, E. Okun, S.C. Tang, J. Thundyil, S.M. Taylor, and T.M. Woodruff Toll-like receptors in ischemia-reperfusion injury Shock 32 2009 4 16
7. H. Bjorkbacka, K.A. Fitzgerald, F. Huet, X. Li, J.A. Gregory, and M.A. Lee The induction of macrophage gene expression by LPS predominantly utilizes MyD88-independent signaling cascades Physiol Genomics 19 2004 319 330
8. H.J. Brown, H.R. Lock, S.H. Sacks, and M.G. Robson TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis J Immunol 177 2006 1925 1931
9. M. Del Rio, A. Imam, M. DeLeon, G. Gomez, J. Mishra, and Q. Ma The death domain of kidney ankyrin interacts with Fas and promotes Fas-mediated cell death in renal epithelia J Am Soc Nephrol 15 2004 41 51
10. M. Delgado, C. Martinez, D. Pozo, J.R. Calvo, J. Leceta, and D. Ganea Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6 J Immunol 162 1999 1200 1205
11. M. Di Michele, K. Peeters, S. Loyen, C. Thys, E. Waelkens, and L. Overbergh Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) impairs the regulation of apoptosis in megakaryocytes by activating NF-κB: a proteomic study Mol Cell Proteomics 11 M111 2011 007625
12. T.M. El-Achkar, and P.C. Dagher Renal Toll-like receptors: recent advances and implications for disease Nat Clin Pract Nephrol 2 2006 568 581
13. C.A. Farrar, B. Keogh, W. McCormack, A. O'Shaughnessy, A. Parker, and M. Reilly Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury FASEB J 26 2012 799 807
14. T. Hamasaki, T. Uto, T. Akagi, M. Akashi, and M. Baba Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles Clin Vaccine Immunol 17 2010 748 756
15. H. Ji, Y. Zhang, X. Shen, F. Gao, C.Y. Huang, and C. Abad Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation via cAMP-PKA pathway Hepatology 2012 10.1002/hep.25802
16. W.J. Kaiser, and M.K. Offermann Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif J Immunol 174 2005 4942 4952
17. H. Kanzler, F.J. Barrat, E.M. Hessel, and R.L. Coffman Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat Med 13 2007 552 559
18. J. Karhausen, G.T. Furuta, J.E. Tomaszewski, R.S. Johnson, S.P. Colgan, and V.H. Haase Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis J Clin Invest 114 2004 1098 1106
19. T. Kawai, and S. Akira Signaling to NF-κB by Toll-like receptors Trends Mol Med 13 2007 460 469
20. T. Kawai, and S. Akira TLR signaling Semin Immunol 19 2007 24 32
21. J.P. Kehrer, S.S. Biswal, E. La, P. Thuillier, K. Datta, and S.M. Fischer Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886 Biochem J 356 2001 899 906
22. A.M. Khan, M. Li, E. Brant, J.L. Maderdrut, D.S. Majid, and E.E. Simon Renoprotection with pituitary adenylate cyclase-activating polypeptide in cyclosporine A-induced nephrotoxicity J Investig Med 59 2011 793 802
23. B.S. Kim, S.W. Lim, C. Li, J.S. Kim, B.K. Sun, and K.O. Ahn Ischemia-reperfusion injury activates innate immunity in rat kidneys Transplantation 79 2005 1370 1377
24. J. Kuhlicke, J.S. Frick, J.C. Morote-Garcia, P. Rosenberger, and H.K. Eltzschig Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia PLoS One 2 2007 e1364
25. S. Lassen, M. Lech, C. Rommele, H.W. Mittruecker, T.W. Mak, and H.J. Anders Ischemia reperfusion induces IFN regulatory factor 4 in renal dendritic cells, which suppresses postischemic inflammation and prevents acute renal failure J Immunol 185 2010 1976 1983
26. M. Lech, A. Avila-Ferrufino, R. Allam, S. Segerer, A. Khandoga, and F. Krombach Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein J Immunol 183 2009 4109 4118
27. J.C. Leemans, G. Stokman, N. Claessen, K.M. Rouschop, G.J. Teske, and C.J. Kirschning Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney J Clin Invest 115 2005 2894 2903
28. M. Li, S. Balamuthusamy, A.M. Khan, J.L. Maderdrut, E.E. Simon, and V. Batuman Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury Peptides 31 2010 592 602
29. M. Li, S. Balamuthusamy, A.M. Khan, J.L. Maderdrut, E.E. Simon, and V. Batuman Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failure J Mol Neurosci 43 2010 58 66
30. M. Li, S. Cortez, T. Nakamachi, V. Batuman, and A. Arimura Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells Cancer Res 66 2006 8796 8803
31. M. Li, K.S. Hering-Smith, E.E. Simon, and V. Batuman Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells Nephrol Dial Transplant 23 2008 860 870
32. M. Li, A.M. Khan, J.L. Maderdrut, E.E. Simon, and V. Batuman The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury Am J Nephrol 32 2010 522 532
33. M. Li, J.L. Maderdrut, J.J. Lertora, A. Arimura, and V. Batuman Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases Regul Pept 145 2008 24 32
34. M. Li, J.L. Maderdrut, J.J. Lertora, and V. Batuman Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: a case study Peptides 28 2007 1891 1895
35. S.S. Mao, R. Hua, X.P. Zhao, X. Qin, Z.Q. Sun, and Y. Zhang Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4/MyD88/NF-κB pathway J Neurotrauma 29 2012 1941 1959
36. M.E. Mendes, G.L. Baggio-Zappia, M.K. Brunialti, L. Fernandes Mda, M.M. Rapozo, and R. Salomao Differential expression of Toll-like receptor signaling cascades in LPS-tolerant human peripheral blood mononuclear cells Immunobiology 216 2011 285 295
37. H. Mori, T. Nakamachi, H. Ohtaki, S. Yofu, A. Sato, and K. Endo Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice Circ J 74 2010 1183 1190
38. A. Ozinsky, D.M. Underhill, J.D. Fontenot, A.M. Hajjar, K.D. Smith, and C.B. Wilson The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors Proc Natl Acad Sci USA 97 2000 13766 13771
39. J.F. Pedregosa, A.A. Haidar, A.E. Hirata, M. Franco, G.N. Gomes, and V. Bueno TLR2 and TLR4 expression after kidney ischemia and reperfusion injury in mice treated with FTY720 Int Immunopharmacol 11 2011 1311 1318
40. X. Qin, Z.Q. Sun, X.J. Dai, S.S. Mao, J.L. Zhang, and M.X. Jia Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation Neurol Res 34 2012 379 389
41. K. Rusai, D. Sollinger, M. Baumann, B. Wagner, M. Strobl, and C. Schmaderer Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury Pediatr Nephrol 25 2010 853 860
42. M. Ruse, and U.G. Knaus New players in TLR-mediated innate immunity: PI3K and small Rho GTPases Immunol Res 34 2006 33 48
43. T. Seaborn, O. Masmoudi-Kouli, A. Fournier, H. Vaudry, and D. Vaudry Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis Curr Pharm Des 17 2011 204 214
44. A.A. Shigeoka, T.D. Holscher, A.J. King, F.W. Hall, W.B. Kiosses, and P.S. Tobias TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways J Immunol 178 2007 6252 6258
45. B. Skaug, X. Jiang, and Z.J. Chen The role of ubiquitin in NF-κB regulatory pathways Annu Rev Biochem 78 2009 769 796
46. N.A. Syed, P.L. Andersen, R.C. Warrington, and W. Xiao Uev1A, a ubiquitin conjugating enzyme variant, inhibits stress-induced apoptosis through NF-κB activation Apoptosis 11 2006 2147 2157
47. P. Szakaly, G. Horvath, P. Kiss, E. Laszlo, J. Farkas, and G. Furjes Changes in pituitary adenylate cyclase-activating polypeptide following renal ischemia-reperfusion in rats Transplant Proc 42 2010 2283 2286
48. P. Szakaly, P. Kiss, A. Lubics, T. Magyarlaki, A. Tamas, and B. Racz Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia/reperfusion J Mol Neurosci 36 2008 89 96
49. O. Takeuchi, and S. Akira MyD88 as a bottle neck in Toll/IL-1 signaling Curr Top Microbiol Immunol 270 2002 155 167
50. M. Triantafilou, F.G. Gamper, R.M. Haston, M.A. Mouratis, S. Morath, and T. Hartung Membrane sorting of Toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting J Biol Chem 281 2006 31002 31011
51. D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, and O. Wurtz Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery Pharmacol Rev 61 2009 283 357
52. D. Vaudry, T.F. Pamantung, M. Basille, C. Rousselle, A. Fournier, and H. Vaudry PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis Eur J Neurosci 15 2002 1451 1460
53. T.G. Wolfs, B. de Vries, S.J. Walter, C.J. Peutz-Kootstra, L.W. van Heurn, and G.O. Oosterhof Apoptotic cell death is initiated during normothermic ischemia in human kidneys Am J Transplant 5 2005 68 75
54. S. Yang, J. Yang, Z. Yang, P. Chen, A. Fraser, and W. Zhang Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress J Pharmacol Exp Ther 319 2006 595 603
55. J.M. Yuk, D.M. Shin, H.M. Lee, J.J. Kim, S.W. Kim, and H.S. Jin The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors Nat Immunol 12 2011 742 751